{
  "case_id": "MN15-21199",
  "year": 2015,
  "patient_info": {
    "age_range": "51 to 64",
    "gender": "Male"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [
    "Retroperitoneal Fibrosis"
  ],
  "complications": [],
  "symptoms": [],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Other",
  "treatments_requested": [
    {
      "name": "Rituximab",
      "drug_type": "biologic",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    }
  ],
  "treatments_tried_but_failed": [],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [],
  "is_denial_upheld": true,
  "issues_considered": [
    "medical_necessity"
  ],
  "other_issues": null,
  "guidelines_support": false,
  "guidelines_not_support": true,
  "guidelines_details": "Rituxan is approved for rheumatoid arthritis, vasculitis, lymphoma, and leukemia, but not for lupus or retroperitoneal fibrosis.",
  "soc_support": false,
  "soc_not_support": true,
  "soc_details": "Rituxan is not standard of care for lupus or retroperitoneal fibrosis.",
  "study_support": false,
  "study_details": [],
  "key_questions": [
    "medical_necessity"
  ],
  "expedited": false,
  "rationale": "The requested medication Rituxan is not medically necessary for the treatment of the patient's medical condition as it is not approved for lupus or retroperitoneal fibrosis.",
  "reviewer_credentials": "Board certified in internal medicine with sub-specialty certification in rheumatology, actively practicing with expertise in the treatment of lupus."
}